Specifically, we identified CXCL5 as a key chemokine in collagen I-induced NET formation and show that the pharmacologic blockade of DDR1 effectively prevents collagen induction of CXCL5, subsequent NET formation, and cancer cell invasion. The gene discussed is CXCL5; the disease is cancer.